314 related articles for article (PubMed ID: 19906785)
1. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy.
Flynn RW; Bonellie SR; Jung RT; MacDonald TM; Morris AD; Leese GP
J Clin Endocrinol Metab; 2010 Jan; 95(1):186-93. PubMed ID: 19906785
[TBL] [Abstract][Full Text] [Related]
2. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.
Thayakaran R; Adderley NJ; Sainsbury C; Torlinska B; Boelaert K; Šumilo D; Price M; Thomas GN; Toulis KA; Nirantharakumar K
BMJ; 2019 Sep; 366():l4892. PubMed ID: 31481394
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
4. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH.
Leese GP; Jung RT; Guthrie C; Waugh N; Browning MC
Clin Endocrinol (Oxf); 1992 Dec; 37(6):500-3. PubMed ID: 1286519
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques.
Walsh JP; Bremner AP; Feddema P; Leedman PJ; Brown SJ; O'Leary P
J Clin Endocrinol Metab; 2010 Mar; 95(3):1095-104. PubMed ID: 20097710
[TBL] [Abstract][Full Text] [Related]
6. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
[TBL] [Abstract][Full Text] [Related]
7. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
8. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial.
Walsh JP; Ward LC; Burke V; Bhagat CI; Shiels L; Henley D; Gillett MJ; Gilbert R; Tanner M; Stuckey BG
J Clin Endocrinol Metab; 2006 Jul; 91(7):2624-30. PubMed ID: 16670161
[TBL] [Abstract][Full Text] [Related]
9. The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis.
Abrahamsen B; Jørgensen HL; Laulund AS; Nybo M; Bauer DC; Brix TH; Hegedüs L
J Bone Miner Res; 2015 May; 30(5):898-905. PubMed ID: 25431028
[TBL] [Abstract][Full Text] [Related]
10. Increased need for thyroxine in women with hypothyroidism during estrogen therapy.
Arafah BM
N Engl J Med; 2001 Jun; 344(23):1743-9. PubMed ID: 11396440
[TBL] [Abstract][Full Text] [Related]
11. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
12. Relationship of thyroid-stimulating hormone levels to development of dyslipidemia and determination of an ideal cut-off point to start replacement therapy.
Sarzosa Terán V; Astudillo Calle MA
Endocrinol Nutr; 2012 Dec; 59(10):575-82. PubMed ID: 23036934
[TBL] [Abstract][Full Text] [Related]
13. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism.
Surks MI; Hollowell JG
J Clin Endocrinol Metab; 2007 Dec; 92(12):4575-82. PubMed ID: 17911171
[TBL] [Abstract][Full Text] [Related]
14. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies.
Checchi S; Montanaro A; Pasqui L; Ciuoli C; De Palo V; Chiappetta MC; Pacini F
J Clin Endocrinol Metab; 2008 Feb; 93(2):465-9. PubMed ID: 18042648
[TBL] [Abstract][Full Text] [Related]
15. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
Konno N; Morikawa K
J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of TSH circadian variability in patients with hypothyroidism.
Sviridonova MA; Fadeyev VV; Sych YP; Melnichenko GA
Endocr Res; 2013; 38(1):24-31. PubMed ID: 22857384
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.
Soppi E; Irjala K; Kaihola HL; Viikari J
Scand J Clin Lab Invest; 1984 Jun; 44(4):353-6. PubMed ID: 6463564
[TBL] [Abstract][Full Text] [Related]
18. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
[TBL] [Abstract][Full Text] [Related]
19. The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism.
Vadiveloo T; Donnan PT; Cochrane L; Leese GP
J Clin Endocrinol Metab; 2011 May; 96(5):1344-51. PubMed ID: 21346066
[TBL] [Abstract][Full Text] [Related]
20. Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement.
Saravanan P; Visser TJ; Dayan CM
J Clin Endocrinol Metab; 2006 Sep; 91(9):3389-93. PubMed ID: 16804044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
